Peripheral Artery Disease (PAD) is a significant global health burden, affecting over 236 million people worldwide1 and presents in 15-20% of people > 70 years of age.2 As a global leader in peripheral intervention, Abbott offers innovative products to treat the full spectrum of PAD and chronic limb threatening ischemia (CLTI).
Every lower limb case is unique, and no lesion is the same. That is why we focus on providing the therapies, tools, and specialized knowledge that enable you to tailor your approach and optimize long-term, durable outcomes.
Our comprehensive portfolio offers individualized solutions for every step in lower limb care from ACCESS to CLOSE.
Gain access with the right guide wires.
Clear obstacles with peripheral dilatation catheters, embolic protection, and orbital atherectomy.
Manage hemostasis efficiently.
Beyond the treatment, make sure your referring physicians are fully aware of PAD and CLTI and how they can help with early diagnosis and timely treatment. For information specifically for the physician, visit our Clear Program webpage. Access a full range of helpful tools and insights.
Helping physicians streamline PAD referral and diagnosis
Request an Abbott Sales Rep
References
MAT-2415122 v1.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
